Medicine and Dentistry
Patient
100%
Child
93%
Oncology
79%
Childhood Cancer
74%
Malignant Neoplasm
66%
Pediatrics
48%
Therapeutic Procedure
48%
Acute Lymphoblastic Leukemia
42%
Young Adult
42%
Pediatric Cancer
37%
Adolescent
31%
Diagnosis
31%
Age
30%
Clinical Trial
27%
Adult
20%
Combination Therapy
19%
Survival
18%
Care Pathway
17%
Survivorship in Cancer Care
17%
Cancer in Young Adults
17%
Neoplasm
15%
Event Free Survival
15%
Cohort Analysis
14%
Experience
14%
Childhood
14%
Analysis
13%
Assessment
13%
Pediatrics Patient
13%
Symptom Management
13%
Quality of Life
12%
Family
12%
Health
11%
Cancer Therapy
11%
Hispanic
11%
Diseases
11%
Comprehension
11%
Development
11%
Overall Survival
10%
Solid Malignant Neoplasm
10%
Male
10%
Evaluation Study
9%
Hyperglycemia
9%
Hemophagocytic Syndrome
9%
Monitoring
9%
Medulloblastoma
9%
Cancer
9%
Morbidity
9%
Radiation Therapy
8%
Obesity
8%
Toxicity
8%
Recurrent Disease
8%
Supportive Care
8%
Ocular Albinism
8%
Cancer Susceptibility
8%
Symptom
7%
Brain Tumor
7%
Parent
7%
Measurement
7%
Osteosarcoma
7%
Prevalence
6%
Chemotherapy
6%
Association
6%
Adolescence
6%
Cardiovascular Disease
6%
Pain
6%
Gender
6%
Infection
6%
COVID-19
6%
Cancer Research
6%
Ganglioneuroblastoma
6%
Radiation
6%
Gene Linkage
6%
Clinical Research
6%
Fever
5%
Biological Marker
5%
Nausea
5%
Adaptation
5%
Coronary Artery Disease
5%
Familial Adenomatous Polyposis
5%
Cancer Survival
5%
Nervous System
5%
Female
5%
Neutropenia
5%
Skill
5%
Needs Assessment
5%
Social Determinants of Health
5%
Cancer Registry
5%
Plasma
5%
Hazard Ratio
5%
Nursing and Health Professions
Child
36%
Pediatrics
13%
Symptom
13%
Patient
13%
Practice Guideline
12%
Chemotherapy
11%
Combination Therapy
11%
Body Mass
9%
Nausea
9%
Childhood Cancer
9%
Adolescent
9%
Screening
8%
Time
8%
Procedures
8%
Acute Lymphoblastic Leukemia
8%
Diagnosis
8%
Hispanic
8%
Methotrexate
7%
Parent
7%
Cohort Analysis
7%
Osteosarcoma
6%
Inpatient
6%
Pain
5%
Malignant Neoplasm
5%
Biochemistry, Genetics and Molecular Biology
Pediatrics
34%
Childhood
27%
Survival
19%
Doxorubicin
18%
Germline
15%
Germ Cell
14%
Solid
10%
Proteomics
9%
Hyperglycemia
9%
Sample
9%
Cohort Study
8%
Age
7%
Mutation
6%
Anthracycline
6%
Mouse
6%
Time
6%
Event Free Survival
6%
Fibroblast
6%
MicroRNA
5%